If this is the case, gaining insights into the mechanism of action and target would be helpful to find out more about collateral sensitivity in BCRP-overexpressing cancer cells and how to exploit this feature in tumor therapy (Pluchino et al., 2012; Rao et al., 2014). Here, ABCG2 is linked to cancer.